.png){kind=icon}
返回
Grid computing in large pharmaceutical molecular modeling
.png){kind=icon}
PRE
AI
DOI：10.1016/j.drudis.2008.03.006.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Most major pharmaceutical companies have employed grid computing to expand their compute resources with the intention of minimizing additional financial expenditure. Historically, one of the issues restricting widespread utilization of the grid resources in molecular modeling is the limited set of suitable applications amenable to coarse-grained parallelization. Recent advances in grid infrastructure technology coupled with advances in application research and redesign will enable fine-grained parallel problems, such as quantum mechanics and molecular dynamics, which were previously inaccessible to the grid environment. This will enable new science as well as increase resource flexibility to load balance and schedule existing workloads.
Keyword:
LIGAND BINDING AFFINITIES
IMPLEMENTATION
DESIGN
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
7.5
论文数:
6.4K
被引数:
2.3W
机构
引用论文
.png){kind=icon}
分享收藏
分享收藏
查看更多内容